Besides, the latest meta-nalysis of Cao et al. showed that the SOD2 rs4880 polymorphism was not associated with bladder cancer risk, while GPX1 rs1050450 polymorphism significantly increased susceptibility to bladder cancer [43]. The gene discussed is GPX1; the disease is urinary bladder cancer.